Vaccine

Article	Citations
Syncope after live attenuated influenza vaccine: Reports to the Vaccine Adverse Event Reporting System (2003–2024)	223
Editorial Board/Aims and Scope	204
Sublingual immunisation with GBS serotype III capsular polysaccharide-tetanus toxoid conjugate vaccine induces systemic and mucosal antibody responses which are opsonophagocytic and inhibit GBS coloni	174
Editorial Board/Aims and Scope	152
Managing multiplicity in clinical vaccine studies – A case study using a gatekeeping testing strategy	151
Editorial Board/Aims and Scope	130
Humoral and cellular immune responses induced by serogroup W135 meningococcal conjugate and polysaccharide vaccines	116
Tackling the burden of mumps in the military: A report of the Defense Health Board	116
TAK − 021, an inactivated Enterovirus 71 vaccine candidate, provides cross-protection against heterologous sub-genogroups in human scavenger receptor B2 transgenic mice	106
Issues with infectious disease vaccine introduction into routine vaccination in Japan, and considerations for accelerating the process	102
Pediatric otitis media in Japan: A nationwide longitudinal study of the pre- and post-pneumococcal conjugate vaccine eras born in 2001 and 2010	99
COVID-19 vaccination communication: Effects of vaccine conspiracy beliefs and message framing among black and white participants	96
Monitoring COVID-19 vaccine use in Italian long term care centers: The GeroCovid VAX study	95
A randomized, blind, parallel controlled phase I clinical trial to evaluate the safety and preliminary immunogenicity of 23-valent pneumococcal polysaccharide vaccine in healthy people aged 2 years an	95
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys	93
“Every interaction you have …should be an opportunity to discuss and offer influenza vaccination”. Health service perspectives on influenza vaccination promotion and delivery to Aboriginal families li	93
Reduced cell-mediated immune response in hyperglycemic NOD mice following influenza vaccination	93
Editorial Board/Aims and Scope	83
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants	83
Erratum to “Motivational interviewing and vaccine acceptance in children: The MOTIVE study” [Vaccine 40(12) (2022) 1846–1854]	82
Erratum to “Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals” [Vaccine 41(37) (2023) 5469-5476]	80
Corrigendum to ‘Cross-protective efficacy of inactivated whole influenza vaccines against Korean Y280 and Y439 lineage H9N2 viruses in mice’ [Vaccine 39 (2021) 6213–6220]	80
Corrigendum to “Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis” [Vaccine 40(41) (2022) 5971	79
Humoral immune response profile of a cattle herd vaccinated with 5- and 10-times Bakirköy strain sheep pox vaccine under field conditions	77
Cost-effectiveness of anti-viral treatment for infants with RSV disease in the United Kingdom	77

Evaluation of dynamics of immune responses and protective efficacy in piglets immunized with an inactivated porcine reproductive and respiratory syndrome vaccine candidate	76
Effectiveness of the varicella vaccine in the real world, a matched case-control study	75
Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study	72
Compliance, procrastination and refusal: American COVID-19 vaccination trust and value orientation	71
Stability studies for the identification of critical process parameters for a pharmaceutical production of the Orf virus	71
Pneumonia hospitalization after introduction of pneumococcal conjugate vaccine in Japan: Descriptive study using a nationwide claims database	69
Long-term impact of rotavirus vaccination on all-cause and rotavirus-specific gastroenteritis and strain distribution in Central Kenya: An 11-year interrupted time-series analysis	69
Evaluating concurrency and gaps between self-report and vaccine card data for COVID-19 vaccination	69
The projected cost-effectiveness and budget impact of HPV vaccine introduction in Ghana	68
Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Incorporating the impact on both respiratory and cardiovascular hospitalizations	67
Relative effectiveness of homologous NVX-CoV2373 and BNT162b2 COVID-19 vaccinations in South Korea	66
UK healthcare professionals’ attitudes towards the introduction of varicella vaccine into the routine childhood vaccination schedule and their preferences for administration	66
Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England	65
Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines	61
Vaccination during febrile illness, what do we know? A systematic-narrative hybrid review of the literature and international recommendations	61
World Health Organization Expert Working Group: Recommendations for assessing morbidity associated with enteric pathogens	59
Sustained antibody persistence for at least 15 years after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules: Third 5-year follow-up	58
Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink	58
Determinants of immunization in polio super high-risk union councils of Pakistan	58
Cost of illness due to pertussis in adults ≥50 years of age in the United Kingdom	58
Epidemiological characteristics and serotype distribution of culture-confirmed pediatric pneumococcal pneumonia before and after PCV 10 introduction, a multicenter study in Bogota, Colombia, 2008–2019	57
Participant-reported neurological events following immunization in the Canadian National Vaccine Safety Network-COVID-19 vaccine (CANVAS-COVID) study	56
Expected endpoints from future chikungunya vaccine trial sites informed by serological data and modeling	55
Why did Brazil fail to vaccinate children against COVID-19 during the pandemic? An assessment of attitudinal and behavioral determinants	55
Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental chal	55
COVID-19 and seasonal flu vaccination hesitancy: Links to personality and general intelligence in a large, UK cohort	54
The methodological quality of economic evaluations of measles outbreaks: A systematic review of cost-of-illness studies	54
Cross-protective efficacy and safety of an adenovirus-based universal influenza vaccine expressing nucleoprotein, hemagglutinin, and the ectodomain of matrix protein 2	53
Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States	52
Behaviors, perceptions, and impact of the COVID-19 pandemic and vaccination on oncology patients in New Mexico with substantial representation of racial minorities and rural residents	52
A decade of rotavirus vaccination in the World Health Organization African Region: An in-depth analysis of vaccine coverage from 2012 to 2023	52
Vaccine efficacy induced by 2020-2021 seasonal influenza-derived H3N1 virus-like particles co-expressing M2e5x or N2	52
Collateral damage from debunking mRNA vaccine misinformation	51
Poor association between 13-valent pneumococcal conjugate vaccine-induced serum and mucosal antibody responses with experimental Streptococcus pneumoniae serotype 6B colonisation	50
Retesting the hypothesis that early Diphtheria-Tetanus-Pertussis vaccination increases female mortality: An observational study within a randomised trial	49
“Fighting the pandemic!” Western Australian pharmacists’ perspectives on COVID-19 vaccines: A qualitative study	49
Nationwide rollout of HPV vaccination in Nepal: Early key insights	49
Integrating the person-centered approach with the study of vaccine hesitancy: Applying latent profile analysis to identify vaccine hesitancy subpopulations and assess their relations with correlates a	49
Vaccine financing in the Middle East and Africa: An overview from 2010 to 2019	49
The U.S. COVID-19 vaccination program: A look back and future directions	49
Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (SynflorixTM and Prevenar13TM)) on nasopharyngeal carriage and serotype-specific immune response in the fi	48
Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria	48
Cost-effectiveness of human papillomavirus vaccination in girls living in Latin American countries: A systematic review and meta-analysis	48
The impact of Facebook’s vaccine misinformation policy on user endorsements of vaccine content: An interrupted time series analysis	47
Immunogenicity and safety of routine 13-valent pneumococcal conjugate vaccination outside recommended age range in patients with hematological malignancies and solid tumors	46
Supply, then demand? Health expenditure, political leanings, cost obstacles to care, and vaccine hesitancy predict state-level COVID-19 vaccination rates	46
Influenza vaccination in children with pulmonary disease during the COVID-19 pandemic	46
The increasing age of respiratory syncytial virus-related hospitalisation during COVID-19 pandemic in Lyon was associated with reduced hospitalisation costs	46
COVID-19 and seasonal influenza: The potential 2021–22 “Twindemic”	45
Social and demographic patterns of influenza vaccination coverage in Norway, influenza seasons 2014/15 to 2020/21	45

Corrigendum to ‘A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and older’ Vac	44
Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic	44
Safety surveillance of varicella vaccine using tree-temporal scan analysis	44
Pre-implementation evaluation for an HPV vaccine provider communication intervention among primary care clinics	44
A place for neutrophils in the beneficial pathogen-agnostic effects of the BCG vaccine	43
Uptake of COVID-19 vaccines among healthcare workers and the effect of nudging interventions: A mixed methods study	43
Mass vaccination campaign during the 2016 influenza outbreak in Panama: Challenges and implications for COVID-19 vaccination efforts	43
Quantitation and characterization of serotype 6A activation for pneumococcal conjugate vaccine by cryo-EM and SEC methods	43
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine	43
Increasing Ebola transmission behaviors 6 months post-vaccination: Comparing vaccinated and unvaccinated populations near 2018 Mbandaka Ebola outbreak in the Democratic Republic of Congo	43
A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults	43
Safety, efficacy, and DIVA feasibility on a novel live attenuated classical swine fever marker vaccine candidate	43
Impact analysis of rotavirus vaccination in various geographic regions in Western Europe	42
Prevalence of indications for adult hepatitis A vaccination among hepatitis A outbreak-associated cases, Three US States, 2016–2019	42
Knowledge, attitudes, and practices of healthcare providers regarding vaccinating children with cancer in Latin America and the Caribbean	42
BBIBP-CorV vaccine effectiveness against COVID-19 in patients aged 60 years and older during the Delta-dominant period in the Federation of Bosnia and Herzegovina, a test-negative case-control study	41
General vaccination willingness and current vaccination status in relation to clinical and psychological variables in patients with multiple sclerosis	41
Knowledge, attitudes, and practices regarding seasonal influenza vaccination during pregnancy in Costa Rica: A mixed-methods study	41
Differences in school factors associated with adolescent HPV vaccination initiation and completion coverage in three Australian states	40
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysacchar	40
Characteristics of reported mumps cases in the United States: 2018–2023	39
Effectiveness of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children <2 years old: A prospective population-based study in rural Bangladesh	39
Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSVΔG-ZEBOV-GP)	39
Immunogenicity and protective efficacy of a trimeric full-length S protein subunit vaccine for porcine epidemic diarrhea virus	39
Vaccination coverage in hematological patients undergoing chemotherapy: Should we move towards personalized vaccination?	38
Timeliness and completeness of serial routine vaccinations among 8062 rural children in southwest China during the COVID-19 pandemic: A multi-stage stratified cluster sampling survey in 1094 villages	38
Parental socioeconomic and psychological determinants of the 2009 pandemic influenza A(H1N1) vaccine uptake in children	38
Safety monitoring of health outcomes following influenza vaccination during the 2023–2024 season among U.S. Commercially-insured individuals aged 6 months through 64 years: Self-controlled case series	38
Genetic markers of enhanced functional antibody responses to COVID-19 vaccination	37
Assessing commutability of the first WHO International Standard for antiserum to respiratory syncytial virus	37
Racial and ethnic differences among Mpox vaccination recipients by vaccination facility type in New York City—August–December 2022	37
Corrigendum to “Recombinant BCGΔBCG1419c protects outbred mice against M. tuberculosis challenge” [Vaccine 61 (2025) 127347]	37
Measles seroprevalence among individuals serologically tested in Ontario, Canada	37
Letter to the editor: SARS-CoV-2 vaccination in children and adolescents with neurodevelopmental or psychiatric disorders	37
HPV vaccination acceptance and perceptions related to fertility and population control in the Gambia: An anthropological analysis	37
A template tool for the evaluation of vaccines for emerging pathogens to be used for pregnant and breast-feeding women	37
IFITM3-deficient mice as a model for testing influenza virus vaccines via the intramuscular route	36
Analysis of HPV vaccination and influencing factors among 9–14-year-old girls in underdeveloped areas of northwestern China: A cross-sectional survey report on guardians	36
Influences of sociodemographic characteristics and parental HPV vaccination hesitancy on HPV vaccination coverage in five US states	36
Assessing vaccination intentions and perceptions among pregnant women in Italy: A multicenter cross-sectional study in the context of mandatory policies and the COVID-19 pandemic	36
Corrigendum to “I want to chat with a person”: a qualitative longitudinal cohort study in England exploring drivers of sub-optimal childhood vaccination uptake” [Vaccine 62 (2025) 127462]	36
Weaving a public health network: Process and results from an evaluation of CDC’s Prevention Research Centers Vaccine Confidence Network	36
Vaccine misinformation among Arabic-speakers in Australia and the audience and appetite for a game-based intervention	36
Purification of recombinant vesicular stomatitis virus-based HIV vaccine candidate	35
A universal live vaccine platform against multiple serotypes Streptococcus suis based on polyvalent antigen protein	35
Have vaccine hesitancy models oversimplified a complex problem to our detriment? The Adapted Royal Society of Canada vaccine uptake framework	35
Healthcare professional and professional stakeholders’ perspectives on vaccine mandates in Switzerland: A mixed-methods study	35
Dynamics of global emergency vaccine stockpiles: A systems analysis and application to cholera	35
Liposomal co-encapsulation of a novel gemini lipopeptide and a CpG-ODN induces a strong Th1 response with the co-activation of a Th2/Th17 profile and high antibody levels	35
U.S. public support and opposition to vaccination mandates in K-12 education in light of the COVID-19 pandemic	35
An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-con	34
100 years of the Bacillus Calmette-Guérin vaccine	34
Use of an adapted participatory learning and action cycle to increase knowledge and uptake of child vaccination in internally displaced persons camps (IVACS): A cluster-randomised controlled trial	34
BCG for the prevention and treatment of allergic asthma	34
Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada	34
A new method for testing avian metapneumovirus vaccine efficacy: Evaluation of tracheal ciliary activity after a challenge	34
A three antigen hepatitis B vaccine induces T cells to Pres1 and Pres2 which correlate with anti HBs antibody titers: An investigation into the immunological mechanisms contributing to high anti-HBs t	33
Identification of T-cell epitopes of the intracellular parasite Babesia bovis by immunopeptidomic analysis of BoLA-II presented peptides	33
Exposure to objective/sensationalist information moderates associations between psychological factors and COVID-19 anti-vaccination attitudes: An experimental study	33
Moderate effectiveness of influenza vaccine in outpatient settings: A test-negative study in Beijing, China, 2023/24 season	33
Editorial Board/Aims and Scope	33
Influenza vaccination uptake among Canadian adults before and during the COVID-19 pandemic: An analysis of the Canadian Longitudinal study on Aging (CLSA)	33
Editorial Board/Aims and Scope	32
Need for a contingency dimension when planning vaccine development in a pandemic environment	32
Editorial Board/Aims and Scope	32
Editorial Board/Aims and Scope	32
Low neutralization of SARS-CoV-2 Omicron BA.5.2.48 and XBB.1 sub-variants in response to breakthrough infection by booster	32
Editorial Board	32
Editorial Board/Aims and Scope	32
Adaptive immune response to a wild boar-derived recombinant hepatitis e virus capsid protein challenge in pigs	31
The age-specific impact of COVID-19 vaccination on medical expenditures and hospitalization duration after breakthrough infection: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) S	31
Nanoparticles displaying fHbp elicit an enhanced antibody response against meningococcal B isolates compared to low valency fHbp antigens	31
Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine	31
Evaluation of anti-Pertussis antibody levels in Iranian infants and children: Is it time to include booster acellular Pertussis Vaccines in the immunization schedule?	31
Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008–2018)	31
Corrigendum to, “Attitudes and beliefs of healthcare providers toward vaccination in the United States: A cross-sectional online survey” [Vaccine (2024) Dec 2 42(26) 126437]	31
Editorial Board/Aims and Scope	31
Genetic and epidemiological description of an outbreak of circulating vaccine-derived polio-virus type 2 (cVDPV2) in Angola, 2019–2020	31
Staff and caregivers' perceptions of digital storytelling to increase influenza vaccine confidence in an urban safety-net healthcare system	31
Single immunization of non-adjuvanted recombinant TTFC-mi3 nanoparticle vaccine elicited a rapid and potent protective immunity against tetanus	31

Evaluation of three hemagglutinin-based vaccines for the experimental control of a panzootic clade 2.3.4.4b A(H5N8) high pathogenicity avian influenza virus in mule ducks	30
How manufacturing won or lost the COVID-19 vaccine race	30
Seroprotection against tetanus in the Italian general population	30
Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022	30
“EvoVax” – A rationally designed inactivated Salmonella Typhimurium vaccine induces strong and long-lasting immune responses in pigs	30
Impact of electronic immunization registries and electronic logistics management information systems in four low-and middle-income countries: Guinea, Honduras, Rwanda, and Tanzania	30
County-level correlates of completed HPV vaccination in Indiana	30
Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization R	30
COVID-19 vaccine preferences in India	30
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022	29
Immunogenicity and immune persistence in 4-year-old children completing four doses of Sabin strain or wild strain inactivated poliovirus vaccine: A phase IV, open-labeled, parallel-controlled observat	29
Efficiency of indirect protection of COVID-19 vaccination and interactions between indirect and direct protection on household transmission	29
Views on COVID-19 vaccination of young children in Ireland, results from a cross-sectional survey of parents	29
Occupation, Worker Vulnerability, and COVID-19 Vaccination Uptake: Analysis of the Virus Watch prospective cohort study	29
Documenting human papillomavirus vaccine refusal among adolescents in electronic health records: A mixed methods study	29
Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study	29
Quadrivalent neuraminidase RNA particle vaccine protects pigs against homologous and heterologous strains of swine influenza virus infection	29
Analysis of health claims data on vaccination coverage in older adults in Bavaria, Germany: Influenza, pneumococcus and herpes zoster	29
Vaccination, human mobility, and COVID-19 health outcomes: Empirical comparison before and during the outbreak of SARS‐Cov-2 B.1.1.529 (Omicron) variant	29
Impact of national introduction of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Bangladesh: Case-control and time-trend studies	29
COVID-19 vaccine attitudes, beliefs, intentions and behaviors among pregnant women within the context of dynamic national policy recommendations in Brazil, Ghana, Kenya, and Pakistan	29
COVID-19 hoax belief endorsement and its implications for vaccine uptake: Investigating the role of perceived threat	28
Comparison of SARS-CoV-2 antibody responses following the second dose of BNT162b2 and mRNA-1273 vaccines in people living with HIV-1	28
Post-vaccination fever in infants: Real-world data analysis using a childcare mobile application	28
Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine design	28
The impact of COVID-19 childhood and adolescent vaccination on mortality in Argentina	28
The efficacy and safety of SYN023 (Zamerovimab and Mazorelvimab injection), the recombinant humanized anti-rabies virus monoclonal antibody mixture, combined with rabies vaccine in a WHO category III	28
A phase 3 randomized trial (STRIDE-9) to evaluate the safety, tolerability, and immunogenicity of V116, a population-specific pneumococcal conjugate vaccine, in pneumococcal vaccine-naïve Japanese adu	28
Randomised controlled trials of behavioural nudges delivered through text messages to increase influenza and COVID-19 vaccine uptake among pregnant women (EPIC study) in Australia	28
Covid-19 and influenza vaccine effectiveness against associated hospital admission and death among individuals over 65 years in Norway: A population-based cohort study, 3 October 2022 to 20 June 2023	28
Mathematical modelling of the 100-day target for vaccine availability after the detection of a novel pathogen: A case study in Indonesia	28
Corrigendum to “Impact of a quadrivalent inactivated influenza vaccine on influenza-associated complications and health care use in children aged 6 to 35 months: Analysis of data from a phase III tria	28
Strategies to improve interprofessional communication regarding maternal and infant RSV immunization	28
Barriers and facilitators associated with migrant parents' decisions regarding childhood vaccinations: A mixed methods systematic review	28
Immune responses in children after vaccination with a typhoid Vi-tetanus toxoid conjugate vaccine in Bangladesh	28
Determinants of COVID-19 vaccine hesitancy and resistance in Russia	28
Coverage of influenza, pneumococcal and zoster vaccination and determinants of influenza and pneumococcal vaccination among adults with cardiovascular diseases in community	28
Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese females 9–45 years of age: A phase 3 open-label study	28
Immune responses and safety of COVID-19 vaccination in atypical hemolytic uremic syndrome patients in Taiwan	27
Immunogenicity and lot-to-lot consistency of booster shot with Sabin inactivated poliomyelitis vaccine in Chinese children aged 18–24 Months: A phase Ⅳ clinical trial	27
Impact of the surge of COVID-19 Omicron outbreak on the intention of seasonal influenza vaccination in Hong Kong: A cross-sectional study	27
HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study	27
Frequency and temporal evolution of COVID-19 vaccination rate among oncological patients undergoing 18F-FDG-PET	27
Harmonized case definitions for endpoints in vaccine efficacy trials are needed	27
Associations between family planning, healthcare access, and female education and vaccination among under-immunized children	27
Evaluation of the humoral response to the third dose of SARS-COV-2 vaccines in liver transplant recipients	27
Donor Unrestricted T Cells: Linking innate and adaptive immunity	27
Prevalence of poliovirus neutralizing antibodies in Italian population: A systematic review and meta-analysis	27
Evaluation of bird-adapted self-amplifying mRNA vaccine formulations in chickens	27
Editorial Board	27
Impact of prior infection and repeated vaccination on post-vaccination antibody titers of the influenza A(H1N1)pdm09 strain in Taiwan schoolchildren: Implications for public health	27
Comparing performance of year-round and campaign-mode influenza vaccination strategies among children aged 6–23 months in Kenya: 2019–2021	27
Changes in depressive symptoms and antibody production following influenza vaccination in adolescents and adults	27
The influenza vaccines roadmap – A better future through improved influenza vaccines	27
Distinct features of SARS-CoV-2 humoral immunity against Omicron breakthrough infection	27
Aggregating human judgment probabilistic predictions of the safety, efficacy, and timing of a COVID-19 vaccine	27
Vaccine value profile for Salmonella enterica serovar Paratyphi A	26
Safe and efficacious inactivated immersion vaccine against KG+ phenotype of emerging bacterial pathogen Lactococcus garvieae for early developmental stage of rainbow trout (Oncorhynchus mykiss) in Ind	26
Construction of a Lactobacillus plantarum-based claudin-3 targeting delivery system for the development of vaccines against Eimeria tenella	26
WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants – Key considerations for global use	26
Analyzing attitudes toward COVID-19 vaccine decision making among pregnant women in Pakistan	26
Vaccines against Neisseria meningitidis serogroup B strains – What does genomics reveal on the Portuguese strain’s coverage	26
Factors associated with vaccination intention and uptake over time in a sample of older Australians	26
COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic	26
Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development	26
UAE efforts in promoting COVID-19 vaccination and building vaccine confidence	26
Mumps virus neurovirulence assessment-impact of viral doses, animal sex and age on results dispersion	26
Use of protective antigen of Bacillus anthracis as a model recombinant antigen to evaluate toll-like receptors 2, 3, 4, 7 and 9 agonists in mice using established functional antibody assays, antigen-s	26
Phenotypic and genetic characterization of a next generation live-attenuated yellow fever vaccine candidate	26
Vaccination patterns and up-to-date status of children 19–35 months, 2011–2021	26
Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among healthcare workers	26
Public health impact and cost-effectiveness of implementing a ‘pre-vaccination screening' strategy with the dengue vaccine in Puerto Rico	26
Consultation report – considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries	26
Are intelligent people more likely to get vaccinated? The association between COVID-19 vaccine adherence and cognitive profiles	25
Concordance of self-reported varicella history and serology among adolescent and adult refugee patients at a primary care clinic in Toronto, Canada	25
Immunogenicity and safety of a SARS-CoV-2 mRNA vaccine (SYS6006) in healthy Chinese participants: A randomized, observer-blinded, placebo-controlled phase 2 clinical trial	25
COVID-19 vaccine decision-making among Black women: A qualitative study	25
In ovo administration of retinoic acid enhances cell-mediated immune responses against an inactivated H9N2 avian influenza virus vaccine	25
Pertussis burden and acellular pertussis vaccine effectiveness in high risk children	25
“COVID is a huge jigsaw puzzle that I am trying to make sense of myself”: Exploring the perceptions towards the COVID-19 vaccine communication strategy in Australia amongst unvaccinated Australian adu	25
Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates	25
Antibody kinetics between birth and three months of life in healthy infants with natural exposure to Group B streptococcus: A UK cohort study	25
Individual-level factors associated with COVID-19 vaccine acceptance among U.S. patients with cancer	25
Corrigendum to “Dendritic cell targeting peptide plus Salmonella FliCd flagellin fused outer membrane protein H (OmpH) demonstrated increased efficacy against infections caused by different Pasteurell	24
The impact of a vaccine mandate and the COVID-19 pandemic on influenza vaccination uptake in Western Australian health care students	24
Increasing vaccination coverage among healthcare workers: Active call and mandatory laws. Data from a large general hospital in Southern Italy	24
Pertussis in Asia: Recent country-specific data and recommendations	24
Cost-utility analysis of the use of the 20-valent anti-pneumococcal vaccine (PCV20) in adults older than 60 years in Spain	24
Comparison of performance of varicella vaccines via infectious disease modeling	24
Applying the COM-B behaviour model to understand factors which impact school immunisation nurses’ attitudes towards designing and delivering a HPV educational intervention in post-primary schools for	24
Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care workers	24
Rotavirus vaccine-derived cases in Belgium: Evidence for reversion of attenuating mutations and alternative causes of gastroenteritis	24
Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: A prospective observational cohort study	24
Antitumoral effectiveness and safety of intravenous versus subcutaneous administration of immunomodulatory peptide GK-1 in a murine breast cancer model	24
Utility of edible plant-derived exosome-like nanovesicles as a novel delivery platform for vaccine antigen delivery	24